Personal tools

PILOTS PROJECTS AND FUNDED PROPOSALS 2003


INVESTIGATOR

PROTOCOL NAME

SUPPORT/FACILITIES

YEAR

Idali Martínez, PhD Identification of Bio-Markers for Early Diagnosis of Dengue Hemorrhagic Fever  COBRE Study Biostatistical Support  2003
Valerie Wojna, MD Cognitive Impairment in Co-Infection of HIV/HCV in Drugs Abusing Hispanics COBRE Study Biostatistical Support 2003
Margarita Irizarry, PhD Identification of Bio-Markers for Prostate Cancer COBRE Study Biostatistical Support 2003
Mildred Vera, PhD Collaborative Care of Depressed Patients with Chronic Health Conditions Biostatistical Support 2003
Carmen Albizu, MD Knowledge of HIV Status and Changes in HIV Behaviors of Poor, Inner City, Drug Using Women: Implications of HIV Prevention - Pilot Study Funding 2003
Glorisa Canino, MD Puerto Rican Neonatal Twin Registry - Pilot Study Funding 2003-ongoing
Lydia López Del Valle, DMD, MPH Periodontal Disease and Prematurity - Pilot Study Outpatient Laboratory Funding 2003-ongoing
Iraida Robledo, PhD Susceptibility Patterns and Genotypic Characterization of H. pylori Isolates from PR - Pilot Study Funding Biostatistical Support 2003-ongoing
Adelfa Serrano, PhD Plasmodium falciparum and Dendritic Interaction - Pilot Study  Funding 2003
Mildred Vera, PhD Evidence Based Treatments for Depression in Medical Patients: Are Treatments Gains Sustained at Follow-up? Funding Biostatistical Support 2003
Loyda Meléndez, PhD Viral Characterization of Plasma and CSF from a Cohort of Puerto Rican Patients with HIV-1 associated Cognitive Impairment Biostatistical  Support 2003
Ana Leticia Mulero, PhD Educational Program for Fall Prevention among Older Adults Biostatistical Support 2003
Loyda Meléndez, PhD High levels of CCR3 HIV-1 co-receptor expressed by Trophoblasts compared with Placental Macrophages and Monocyte derived Macrophages Biostatistical Support 2003
Valerie Wojna, MD MRS and HIV Dementia in Puerto Rican Women Funding Biostatistical Support 2003-ongoing
Loyda Mélendez, PhD Immune and Viral Signatures of Macrophage Secretory Function in HIV-1 Dementia Biostatistical Support 2003
Belinda Beauchamp, MD A Stratified, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating The Safety and Efficacy of The Fluticasone Propionate/Salmeterol Diskus Combination Product 100/50 mcg Once Daily versus Fluticasone Propionate Diskus 100 mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4 to 11 years) with Asthma Outpatient Biostatistical Laboratory Support 2003-2004
Esther Torres, MD Mapping Genes for IBD in Puerto Ricans Outpatient  Biostatistical  Laboratory Support 2003-ongoing
Lourdes García, MD MTHFR mutations and Homocysteine in Children with Congestive Heart Disease  Outpatient Biostatistical Laboratory Support 2003-ongoing
Lourdes García, MD Folate and Homocysteine Levels in Puerto Rican Women after Mandatory Folic Acid Supplementation of Grain Derived Products Biostatistical Laboratory Support 2003-ongoing
Lydia López Del Valle, DMD, MPH The Association between Food Preferences and Early Childhood Caries in Children between 3-5 years old Outpatient 2003
David Martínez, MD A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Use Study to Evaluate the Safety and Tolerability of BMS-188667 Administered Intravenously to Subjects with Active Rheumatoid Arthritis (RA) with or without Medical Co-Morbidities Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs) and/or Biologics Approved for RA Outpatient Laboratory  Support 2003-ongoing
Margarita Ramírez Vick, MD Effect of AC2993 (Synthetic Exendin-4) Compared with Insulin Glargine in Patients with Type 2 Diabetes also using Combination Therapy with Sulfonylurea and Metformin Outpatient Laboratory Support 2003-2004
Myriam Allende, MD Effect of AC2993 (Synthetic Exendin-4) Compared with Insulin Glargine in Patients with Type 2 Diabetes also using Combination Therapy with Sulfonylurea and Metformin Outpatient Laboratory Support 2003
Lourdes Guerríos, MD Switching from Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Multinational Assessment of Treatment Preference  Outpatient Laboratory Support 2003-2004
Myriam Z. Allende Vigo, MD A Multinational, Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, 2X2 Factorial Design Study of the Efficacy and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT) Outpatient Laboratory Support 2003
Luis Vilá, MD Case Control Study in Systemic Lupus Erythematosus Outpatient Laboratory  Support 2003-ongoing
Iván Pacheco López, MD Bone Graft for Inter-Fragmentary Analgesic Delivery in Fractures of the Distal Radius Laboratory  Support 2003-2004
Edna Negrón, Ed.D  Biological Agents  Exposure and Health Effects  Biostatistical Support 2003-2004
Vanessa E. Rodríguez, MD Anticardiolipin Antibodies in Patients with Raynaud's Phenomenon Biostatistical Support 2003-ongoing
Irma Febo, MD Connect to Protect (C2P): Partnerships for Youth Prevention Interventions ATN 016 Biostatistical Support 2003-ongoing
Juan Rivera, MD Infants Short Term Outcome after High Frequency Oscillatory Ventilation Biostatistical Support 2003-ongoing
Mikhail Antoun, PhD Clinical and Mechanistics Studies of Lupinus termis Seeds Extract Biostatistical Support 2003
Guillermo Vázquez, MD Detection of Extended-Spectrum Beta Lactamases in E. coli and K. pneumoniae Clinical Isolates from the Puerto Rico Medical Center  Biostatistical Support 2003-ongoing
Miguel Fiol, MD Genetics Studies of Epilepsy Informative Population  Outpatient 2003-ongoing
Carlos Luciano, MD A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Evaluated the Efficacy and Safety of Prosaptide over 6 weeks of Treatment for the Relief of Neuropathic Pain Associated with HIV-1 Outpatient Laboratory  Support 2003-ongoing
Armando López Tristani, MD The Effects of Gabapentin, Rofecoxib and Placebo on Acute Post-Operative Pain After Open Reduction and Internal Fixation of Malleolar Fractures Biostatistical Support 2003-2004
Irma Febo, MD An Open-Label Study to Evaluate The Safety, Tolerance Anti-Viral Activity and Pharmacokinetics of Emtricitamine in Combination with Efavirenz and Didanosine in a Once Daily Regimen in HIV Infected Antiretroviral Exposed Pediatric Subjects Outpatient  Pk 8hrs 2003-2004
Ruth Soto, MD Pattern of HIV Genotyping Drug Resistance among a Puerto Rican Population and their Clinical Outcomes Biostatistical Support 2003-2004
Pablo Costas, MD MELD score as a Predictor of Morbidity and Mortality in Patients with Chronic Liver Disease Hospitalized for Acute Variceal Bleeding Biostatistical Support 2003-ongoing
Esther Torres, MD Infliximab for Crohn's Disease: Experience at a Puerto Rican Center Biostatistical Support 2003-ongoing
Document Actions

The website is supported in part by Grant Number G12RR03051(RCMI Program, UPR Medical Sciences Campus) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH).
Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.